Christopher Paul Simms
Insider Reports History
- Location
- New York, NY
- Signature
- /s/ Scott Bizily as Attorney-in-Fact for Christopher Paul Simms
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Christopher Paul Simms:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | Chief Commercial and Business Officer | Stock Option (Right to Buy) | 219,000 | 25 Mar 2026 | Direct | ||
| IVERIC bio, Inc. | SVP, Chief Commercial Officer | Common Stock | 0 | $39.45 | 11 Jul 2023 | Direct | |
| IVERIC bio, Inc. | SVP, Chief Commercial Officer | Restricted Stock Units | 0 | 11 Jul 2023 | Direct | ||
| IVERIC bio, Inc. | SVP, Chief Commercial Officer | Stock Option (Right to Buy) | 0 | $10.03 | 11 Jul 2023 | Direct |